Evaluation of cancer drug infusion devices prior to the implementation of a compounding robot.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
PMID: 37203170

Abstract

INTRODUCTION: Compounding robots are increasingly being implemented in hospital pharmacies. In our hospital, the recent acquisition of a robot (RIVA, ARxIUM) for intravenous cancer drug compounding obliged us to replace the previously used infusion devices. The objective of the present study was to assess and qualify the new intravenous sets prior to their use in our hospital and prior to the implementation of the compounding robot.

Authors

  • Guillaume Caron
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Michèle Vasseur
    Pharmacie centrale, centre hospitalier universitaire de Lille, rue Philippe-Marache, 59037 Lille cedex, France.
  • Justin Courtin
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Morgane Masse
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Bertrand Décaudin
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Stéphanie Genay
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Pascal Odou
    Institut de Pharmacie, CHU Lille, Lille, France.
  • Nicolas Simon
    Institut de Pharmacie, CHU Lille, Lille, France.

Keywords

External Resources

Popular Topics
Recent Journals